🔗 Share this article

A shadow market for unlicensed weight-loss medications is being driven by TikTok fitness influencers and sellers on messaging platforms, according to new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed fat-burning effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers market the drug there before redirecting customers to other platforms for transactions.

Learning About The Experimental Drug

This medication is an investigational injection developed by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unapproved medication in the UK is worrisome and could result in users injecting substances of unknown origin.

Some professionals said the demand for retatrutide could be connected to the rising cost of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Response and Content Elimination

According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization stated it was committed to keeping the service secure and investing in enhancing compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with images of slimming results, positive testimonials and detailed guides for preparing or administering at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases occur. The vendor sent an guidebook and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one vendor said: “You can’t be sure.” Another provided a image of a alleged testing documentation. None inquired about weight, health issues or previous experience.

Product Information and Pricing

Within these communities, messages show black plastic parcels with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a pen should last, sellers give conflicting answers ranging from a several days to “depends on your body”.

Platform Oversight and Safety Measures

A representative for the messaging service said it regularly moderated harmful material on its platform including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is valid, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to current price rises for approved slimming medications such as Mounjaro. “With prices increasing, individuals are turning to social media. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was clean,” she said.

Her staff has already encountered patients harmed by personal administration from unverified suppliers. “We understand the frustration, but buying from messaging apps or communication platforms is gambling with your well-being,” stated Wyllie. “These substances could be impure or incorrectly dosed.”

Manufacturer Statement

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been evaluated or approved by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to possibly significant health risks”.